Kaitlin M. Kestenberg-Messina serves as COO and SVP, Compliance of ADMA BIOLOGICS, INC. (ADMA). Kestenberg-Messina has reported 8 insider filings with the SEC since 2024. The most recent filing was in July 2026.
Every role Kaitlin M. Kestenberg-Messina has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
ADMA BIOLOGICS, INC. (ADMA)1 filingLatest filing:
Kaitlin M. Kestenberg-Messina is COO and SVP, Compliance of ADMA BIOLOGICS, INC. (ADMA). 8 SEC Form 4 filings on record going back to 2024, most recently on 29 July 2026. Most recent open-market trade: sold $158K of ADMA on 11 March 2026. Lifetime open-market sales: $158K.
Every recent SEC Form 4 transaction Kaitlin M. Kestenberg-Messina has reported, most recent first.
InsiderAlpha's records for Kaitlin M. Kestenberg-Messina go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Insiders who reported open-market trades in the last 12 months at the companies Kaitlin M. Kestenberg-Messina files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Kaitlin M. Kestenberg-Messina is a corporate insider, tracked as COO and SVP, Compliance of ADMA BIOLOGICS, INC. (ADMA). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
1 primary Form 4 filing in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases and 1 open-market sale ($158K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$ADMA ADMA BIOLOGICS, INC.10.1K shares @ $15.63$158K